• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

颅咽管瘤患者随访 16 年后的骨折、骨密度和最终身高。

Fractures, Bone Mineral Density, and Final Height in Craniopharyngioma Patients with a Follow-up of 16 Years.

机构信息

Department of Medicine, Endocrinology; Erasmus Medical Center, GD Rotterdam, The Netherlands.

Department of Paediatric Oncology/Haematology, Erasmus MC - Sophia Children's Hospital, CN Rotterdam, The Netherlands.

出版信息

J Clin Endocrinol Metab. 2020 Apr 1;105(4):e1397-407. doi: 10.1210/clinem/dgz279.

DOI:10.1210/clinem/dgz279
PMID:32145029
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7060760/
Abstract

CONTEXT

Pituitary hormonal deficiencies in patients with craniopharyngioma may impair their bone health.

OBJECTIVE

To investigate bone health in patients with craniopharyngioma.

DESIGN

Retrospective cross-sectional study.

SETTING

Dutch and Swedish referral centers.

PATIENTS

Patients with craniopharyngioma (n = 177) with available data on bone health after a median follow-up of 16 years (range, 1-62) were included (106 [60%] Dutch, 93 [53%] male, 84 [48%] childhood-onset disease).

MAIN OUTCOME MEASURES

Fractures, dual X-ray absorptiometry-derived bone mineral density (BMD), and final height were evaluated. Low BMD was defined as T- or Z-score ≤-1 and very low BMD as ≤-2.5 or ≤-2.0, respectively.

RESULTS

Fractures occurred in 31 patients (18%) and were more frequent in men than in women (26% vs. 8%, P = .002). Mean BMD was normal (Z-score total body 0.1 [range, -4.1 to 3.5]) but T- or Z-score ≤-1 occurred in 47 (50%) patients and T-score ≤-2.5 or Z-score ≤-2.0 in 22 (24%) patients. Men received less often treatment for low BMD than women (7% vs. 18%, P = .02). Female sex (OR 0.3, P = .004) and surgery (odds ratio [OR], 0.2; P = .01) were both independent protective factors for fractures, whereas antiepileptic medication was a risk factor (OR, 3.6; P = .03), whereas T-score ≤-2.5 or Z-score ≤-2.0 was not (OR, 2.1; P = .21). Mean final height was normal and did not differ between men and women, or adulthood and childhood-onset patients.

CONCLUSIONS

Men with craniopharyngioma are at higher risk than women for fractures. In patients with craniopharyngioma, a very low BMD (T-score ≤-2.5 or Z-score ≤-2.0) seems not to be a good predictor for fracture risk.

摘要

背景

颅咽管瘤患者的垂体激素缺乏可能会损害其骨骼健康。

目的

研究颅咽管瘤患者的骨骼健康状况。

设计

回顾性横断面研究。

地点

荷兰和瑞典的转诊中心。

患者

纳入了 177 名颅咽管瘤患者(中位随访时间为 16 年[范围为 1-62 年],可获得骨骼健康数据)(106 名[60%]荷兰人,93 名[53%]男性,84 名[48%]为儿童发病)。

主要观察指标

骨折、双能 X 线吸收法测定的骨密度(BMD)和最终身高。低 BMD 定义为 T-或 Z-评分≤-1,极低 BMD 定义为≤-2.5 或≤-2.0。

结果

31 名患者(18%)发生骨折,男性比女性更常见(26%比 8%,P=.002)。平均 BMD 正常(全身 Z-评分 0.1[范围-4.1 至 3.5]),但 47 名(50%)患者的 T-或 Z-评分≤-1,22 名(24%)患者的 T-评分≤-2.5 或 Z-评分≤-2.0。与女性相比,男性接受低 BMD 治疗的比例较低(7%比 18%,P=.02)。女性(OR 0.3,P=.004)和手术(OR 0.2;P=.01)是骨折的独立保护因素,而抗癫痫药物是危险因素(OR 3.6;P=.03),而 T-评分≤-2.5 或 Z-评分≤-2.0 则不是(OR 2.1;P=.21)。平均最终身高正常,男女之间或成年期和儿童期发病的患者之间无差异。

结论

颅咽管瘤男性患者骨折风险高于女性。在颅咽管瘤患者中,极低的 BMD(T-评分≤-2.5 或 Z-评分≤-2.0)似乎不是骨折风险的良好预测指标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9962/7060760/7b5922c57b72/dgz279f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9962/7060760/daa6ede0cde0/dgz279f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9962/7060760/7b5922c57b72/dgz279f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9962/7060760/daa6ede0cde0/dgz279f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9962/7060760/7b5922c57b72/dgz279f0002.jpg

相似文献

1
Fractures, Bone Mineral Density, and Final Height in Craniopharyngioma Patients with a Follow-up of 16 Years.颅咽管瘤患者随访 16 年后的骨折、骨密度和最终身高。
J Clin Endocrinol Metab. 2020 Apr 1;105(4):e1397-407. doi: 10.1210/clinem/dgz279.
2
Body Composition and Bone Mineral Density in Craniopharyngioma Patients: A Longitudinal Study Over 10 Years.颅咽管瘤患者的身体成分和骨矿物质密度:长达 10 年的纵向研究。
J Clin Endocrinol Metab. 2020 Dec 1;105(12). doi: 10.1210/clinem/dgaa607.
3
Risk and determinants of low and very low bone mineral density and fractures in a national cohort of Dutch adult childhood cancer survivors (DCCSS-LATER): a cross-sectional study.荷兰成年儿童癌症幸存者(DCCSS-LATER)队列中的低骨密度和极低骨密度及骨折风险和决定因素:一项横断面研究。
Lancet Diabetes Endocrinol. 2023 Jan;11(1):21-32. doi: 10.1016/S2213-8587(22)00286-8. Epub 2022 Dec 10.
4
Lumbar bone mineral density at final height and prevalence of fractures in treated children with GH deficiency.生长激素缺乏症患儿经治疗后的最终身高时的腰椎骨密度及骨折患病率。
J Clin Endocrinol Metab. 2002 Aug;87(8):3624-31. doi: 10.1210/jcem.87.8.8754.
5
The impact of height on low/reduced bone mineral density in Chinese adolescents aged 12-14 years old: gender differences.身高对 12-14 岁中国青少年低/骨量减少骨密度的影响:性别差异。
Arch Osteoporos. 2019 Jul 8;14(1):78. doi: 10.1007/s11657-019-0606-1.
6
Peak bone mineral density, lean body mass and fractures.峰值骨密度、瘦体重与骨折。
Bone. 2010 Feb;46(2):336-41. doi: 10.1016/j.bone.2009.10.003. Epub 2009 Oct 13.
7
Does a childhood fracture predict low bone mass in young adulthood? A 27-year prospective controlled study.儿童时期骨折是否预示着青年期骨量低?一项 27 年的前瞻性对照研究。
J Bone Miner Res. 2013 Feb;28(2):351-9. doi: 10.1002/jbmr.1743.
8
Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis.安大略省双能X线吸收法骨密度测定的应用:基于证据的分析。
Ont Health Technol Assess Ser. 2006;6(20):1-180. Epub 2006 Nov 1.
9
Severity of reduced bone mineral density and risk of fractures in long-term survivors of childhood leukemia and lymphoma undergoing guideline-recommended surveillance for bone health.儿童期白血病和淋巴瘤长期幸存者在接受推荐的骨骼健康监测时,其骨密度降低的严重程度和骨折风险。
Cancer. 2020 Jan 1;126(1):202-210. doi: 10.1002/cncr.32512. Epub 2019 Sep 19.
10
Hypothalamic involvement and insufficient sex steroid supplementation are associated with low bone mineral density in women with childhood onset craniopharyngioma.下丘脑受累和性激素补充不足与儿童期发病颅咽管瘤女性的骨密度降低有关。
Eur J Endocrinol. 2011 Jul;165(1):25-31. doi: 10.1530/EJE-11-0229. Epub 2011 Apr 18.

引用本文的文献

1
Endocrine sequelae after pediatric craniopharyngioma treatment: a single-center retrospective cohort study.儿童颅咽管瘤治疗后的内分泌后遗症:单中心回顾性队列研究。
J Pediatr Endocrinol Metab. 2024 Oct 1;37(11):954-961. doi: 10.1515/jpem-2024-0275. Print 2024 Nov 26.
2
Hypogonadism as a consequence of craniopharyngioma in female patients: comparison of childhood and adult onset and effects of estrogen replacement therapy.颅咽管瘤导致女性患者性腺功能减退症:儿童期和成年期发病的比较及雌激素替代治疗的影响。
Endocrine. 2024 Sep;85(3):1425-1434. doi: 10.1007/s12020-024-03872-7. Epub 2024 May 18.
3
Bone mineral density in adults growth hormone deficiency with different ages of onset: a real-world retrospective study.

本文引用的文献

1
Craniopharyngioma.颅咽管瘤。
Nat Rev Dis Primers. 2019 Nov 7;5(1):75. doi: 10.1038/s41572-019-0125-9.
2
Diagnosing metabolic syndrome in craniopharyngioma patients: body composition versus BMI.诊断颅咽管瘤患者的代谢综合征:身体成分与 BMI 相比。
Eur J Endocrinol. 2019 Aug;181(2):173-183. doi: 10.1530/EJE-19-0181.
3
Osteoporosis: a clinical and pharmacological update.骨质疏松症:临床与药理学更新。
不同发病年龄的成人生长激素缺乏症患者的骨矿物质密度:一项真实世界回顾性研究
Endocrine. 2024 Jul;85(1):347-355. doi: 10.1007/s12020-024-03786-4. Epub 2024 Mar 27.
4
Bone mineral density surveillance for childhood, adolescent, and young adult cancer survivors: evidence-based recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group.儿童、青少年和青年癌症幸存者的骨矿物质密度监测:国际儿童癌症晚期效应指南协调组的循证建议。
Lancet Diabetes Endocrinol. 2021 Sep;9(9):622-637. doi: 10.1016/S2213-8587(21)00173-X. Epub 2021 Jul 30.
Clin Rheumatol. 2019 Feb;38(2):385-395. doi: 10.1007/s10067-018-4370-1. Epub 2018 Dec 12.
4
Childhood Craniopharyngioma: A 22-Year Challenging Follow-Up in a Single Center.儿童颅咽管瘤:单中心 22 年的挑战性随访。
Horm Metab Res. 2018 Sep;50(9):675-682. doi: 10.1055/a-0641-5956. Epub 2018 Jun 29.
5
Excess morbidity and mortality in patients with craniopharyngioma: a hospital-based retrospective cohort study.颅咽管瘤患者的额外发病和死亡情况:一项基于医院的回顾性队列研究。
Eur J Endocrinol. 2018 Jan;178(1):93-102. doi: 10.1530/EJE-17-0707. Epub 2017 Oct 18.
6
Effects of growth hormone therapy on bone density and fracture risk in age-related osteoporosis in the absence of growth hormone deficiency: a systematic review and meta-analysis.生长激素治疗对无生长激素缺乏的年龄相关性骨质疏松症骨密度和骨折风险的影响:系统评价和荟萃分析。
Endocrine. 2018 Jan;59(1):39-49. doi: 10.1007/s12020-017-1440-0. Epub 2017 Oct 13.
7
Very long-term sequelae of craniopharyngioma.颅咽管瘤的极长期后遗症。
Eur J Endocrinol. 2017 Jun;176(6):755-767. doi: 10.1530/EJE-17-0044. Epub 2017 Mar 21.
8
Gender differences in the incidence of and risk factors for hip fracture: A 16-year longitudinal study in a southern European population.髋部骨折发病率及危险因素的性别差异:一项针对南欧人群的16年纵向研究。
Maturitas. 2017 Mar;97:38-43. doi: 10.1016/j.maturitas.2016.12.009. Epub 2016 Dec 28.
9
Association Between Hyponatremia, Osteoporosis, and Fracture: A Systematic Review and Meta-analysis.低钠血症、骨质疏松症与骨折之间的关联:一项系统评价与荟萃分析
J Clin Endocrinol Metab. 2016 Apr;101(4):1880-6. doi: 10.1210/jc.2015-4228. Epub 2016 Feb 25.
10
Imaging methods for analyzing body composition in human obesity and cardiometabolic disease.用于分析人类肥胖和心血管代谢疾病中身体成分的成像方法。
Ann N Y Acad Sci. 2015 Sep;1353:41-59. doi: 10.1111/nyas.12842. Epub 2015 Aug 6.